科研项目

[1] 薛付忠 国家自然科学基金面上项目 系统流行病学中网络差异比较的统计分析方法研究（81573259），2016.01-2019.12；（第一位）72万

[2] 薛付忠 山东省科技重大专项，基于临床组学大数据的结直肠癌精准医学技术平台构建及精准诊疗决策支持系统研发，2015.08-2019.08 78.9万

[3] 薛付忠 山东省科技发展计划 人群冠状动脉粥样硬化早期筛查关键技术的研究(2014GSF118119) 2015.01-2017.12；（第一位）8万

[4] 薛付忠 国家自然科学基金项目，基于贝叶斯竞争风险理论的农村人群脑卒中发生和转归的适宜性风险预警策略与方法研究(81273177), 2012.10-2016.12,（第一位）60万元

[5] 薛付忠 科技部国际合作重大项目，人群脑动脉硬化性疾病早期识别关键技术合作研究（S2014ZR0461），2015.01-2017.12,；（第一位）420万元

[6] 薛付忠 科技部“863”项目，复杂疾病基因定位研究的基因（环境）交互作用与遗传交互网络模型构建及其软件系统的开发（2007AA02Z312” 2007.06-2010.7，（第一位）104.5万元

[7] 薛付忠 国家科技支撑计划项目，重大神经精神系统疾病的预警指标体系研究与预警模型开发（2008BAI52B03）；2008.9-2011.9；（第二位）20万元

[8] 薛付忠 横向科研项目，山大/康平健康(疾病)风险评估与个性化干预系统，2014.07-2019.7; （第一位）500万元

…………

建立了健康/疾病风险评估与个性化干预的理论方法体系；发展了多个疾病预测模型，发表SCI论文50余篇；为健康保险提供了精算依据。

山东大学健康医疗大数据研究院-接力互动共管中某关键环节上的智能决策过程及结果展示

发表论文

Li J, Liu R, Ji X, Xue H, Zhang G, Wang C, Chen Q, Xue F*, Cui L*. Insight into the Spectrum of Coronary Atherosclerosis in Asymptomatic Urban Han Chinese Population by Coronary Computed Tomography Angiography. PLoS One. 2015 Jul 7;10(7):e0132188.

Zhang T, Zhang C, Zhang Y, Tang F, Li H1, Zhang Q, Lin H, Wu S, Liu Y, Xue F*. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study. Atherosclerosis. 2015 ;240(1):144-8.

Zhang W, Chen Q, Yuan Z, Liu J, Du Z, Tang F, Jia H, Xue F, Zhang C. A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population. BMC Public Health. 2015 Jan 31;15:64.

Wang S, Liu Y, Li F, Jia H, Liu L, Xue F*.A novel quantitative body shape score for detecting association between obesity and hypertension in China. BMC Public Health. 2015 Jan 17;15:7.

Liu J, Lin H, Zhang C, Wang L, Wu S, Zhang D, Tang F, Xue F, Liu Y.Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population. BMC Gastroenterol. 2014 Dec 13;14:213.

Zhao M, Liu F, Liu W, Ji X, Xue F*. Health management in China. Int J Cardiol. 2014 ;176(1):234.

Zhang T, Zhang Y, Zhang C, Tang F, Li H, Zhang Q, Lin H, Wu S, Liu Y, Xue F*. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study. PLoS One. 2014 May 6;9(5):e96651.

Zhu Z, Liu Y, Zhang C, Yuan Z, Zhang Q, Tang F, Lin H, Zhang Y, Liu L, Xue F*. Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study. PLoS One. 2013 Dec 17;8(12):e84204.

Wu S, Lin H, Zhang C, Zhang Q, Zhang D, Zhang Y, Meng W, Zhu Z, Tang F, Xue F, Liu Y.Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health. 2013 Oct 21;13:989.

Meng W, Zhang C, Zhang Q, Song X, Lin H, Zhang D, Zhang Y, Zhu Z, Wu S, Liu Y, Tang F, Yang X, Xue F*. Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. PLoS One. 2012;7(11):e49875.

Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, Zhang Y, Zhu Z, Tang F, Liu L, Xue F*. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health. 2012 Jun 8;12:419

…………